GPT-Rosalind
GPT-Rosalind has model metadata, but missing tracked provider pricing keeps it from being a default production pick.
Use it for
- Teams evaluating agents and json / tool use
Do not use it for
- Cost-sensitive launches that need sourced token pricing
- Vision or document-understanding workloads
- Teams that need a tracked hosted API route today
- Family
- GPT-Rosalind
- Released
- 2026-04-16
- Architecture
- Decoder Only
- Specialization
- medical
About
GPT-Rosalind is OpenAI's frontier reasoning model purpose-built for life sciences research, including biology, drug discovery, and translational medicine. Released April 16, 2026 via a restricted trusted access program (no public API). Outperforms GPT-5.4 on 6 of 11 LabBench 2 tasks (e.g., experimental design and literature retrieval) and on Bixbench for bioinformatics. Integrates with 50+ scientific tools via a Codex plugin. Access is limited to qualified research organizations through OpenAI's trusted access program. Parameters, context window, and pricing are not publicly disclosed.
GPT-Rosalind is a proprietary model. The structured metadata tracks reasoning, function calling, and tool use. No headline benchmark score is tracked for GPT-Rosalind yet.
Top use-case fit: coding, agents, and build tasks
Agents
Included by capability and metadata signals in the decision map.
JSON / Tool use
Included by capability and metadata signals in the decision map.
Provider price ladder
No tracked provider token pricing is available for this model yet.
Capabilities
Benchmark peer barsfor Agents
No task-mapped benchmark peers are available for this model yet.
Migration checks
No linked migration route is available for this model yet.